Stock Updates

Is AstraZeneca PLC(NYSE: AZN), a large market cap stock a smart buy?

With a market cap of has a large market cap size. AstraZeneca PLC (NYSE: AZN) has been on the stock market since its IPO date on the 5/17/1993. AstraZeneca PLC is in the Drug Manufacturers – Major industry and Healthcare sector. Average volume for AstraZeneca PLC, is 6125.58, and so far today it has a volume of 3782400. Performance year to date since the 5/17/1993 is 4.68%.

To help you determine whether AstraZeneca PLC is undervalued the following values will help you decide. P/E is 38.69 and forward P/E is 12.72. PEG perhaps more useful shows that AstraZeneca PLC has a value for PEG of *TBA. P/S ratio is 3.55 and the P/B ratio is 6.35. The P/Cash and P/Free cash flow is 18.4 and *TBA respectively.

At the current price AstraZeneca PLC is trading at, 33.97 (-0.90% today), AstraZeneca PLC has a dividend yield of 2.65%, and this is covered by a payout ratio of 108.10%. Earnings per share (EPS) is 0.88, and this is looking to grow in the next year to -10.10% after growing 128.90% this past year. EPS growth quarter over quarter is -100.40%, and -11.20% for sales growth quarter over quarter.

The number of shares outstanding is 2516.82, and the number of shares float is 2503.7. The senior management bring insider ownership to 0.50%, and institutional ownership is at 12.20%. The float short is 1.06%, with the short ratio at a value of 4.34. Management has seen a return on assets of 3.70%, and also a return on investment of 11.50%.

The ability for AstraZeneca PLC, to deal with debt, means it current ratio is 0.9, and quick ratio is 0.8. Long term debt/equity is 1.22 and total debt/equity is 1.3. In terms of margins, AstraZeneca PLC has a gross margin of 82.20%, with its operating margin at 15.00%, and AstraZeneca PLC has a profit margin of 9.20%.

The 52 week high is -1.76%, with 27.64% being its 52 week low. The 20 day simple moving average is 3.47% and the 200 day simple moving average is 12.50%.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Peter Clarke

Leave a Comment